| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication | 
|---|
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of CEP57 mRNA | affects expression | 21346803 
 | 
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in increased expression of CEP57 mRNA | increases expression | 20406850 
 | 
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CEP57 mRNA | increases expression | 14703492 
 | 
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEP57 mRNA | decreases expression | 20018196 19150397
 
 | 
| C006780 | bisphenol A | bisphenol A results in decreased expression of CEP57 mRNA | decreases expression | 20678512 
 | 
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA | decreases expression | 15336504 
 | 
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CEP57 mRNA | increases expression | 20106945 
 | 
| C014347 | decitabine | decitabine results in decreased expression of CEP57 mRNA | decreases expression | 19363521 
 | 
| C014347 | decitabine | TP53 protein affects the reaction [decitabine results in decreased expression of CEP57 mRNA] | affects reaction|decreases expression | 19363521 
 | 
| D008727 | Methotrexate | CEP57 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747 
 | 
| D016685 | Mitomycin | CEP57 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747 
 | 
| D011374 | Progesterone | Progesterone results in increased expression of CEP57 mRNA | increases expression | 18070364 
 | 
| D012643 | Selenium | [Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA | affects cotreatment|decreases expression | 19244175 
 | 
| D012643 | Selenium | Selenium results in decreased expression of CEP57 mRNA | decreases expression | 19244175 
 | 
| C004648 | testosterone enanthate | testosterone enanthate affects the expression of CEP57 mRNA | affects expression | 17440010 
 | 
| D014810 | Vitamin E | [Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA | affects cotreatment|decreases expression | 19244175 
 | 
| D014810 | Vitamin E | Vitamin E results in decreased expression of CEP57 mRNA | decreases expression | 19244175 
 | 
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication | 
|---|
| MESH:D000014 | Abnormalities, Drug-Induced |  | Methotrexate | 4.33 | 12039119 | 
| MESH:D000230 | Adenocarcinoma |  | arsenic trioxide | 2.30 | 19825857	11798837 | 
| MESH:D001172 | Arthritis, Rheumatoid |  | Methotrexate | 3.11 | 17286800 | 
| MESH:D001778 | Blood Coagulation Disorders |  | arsenic trioxide | 3.72 | 16206674 | 
| MESH:D001862 | Bone Resorption |  | bisphenol A | 3.92 | 11985600 | 
| MESH:D020201 | Brain Hemorrhage, Traumatic |  | Progesterone | 5.43 | 17868700 | 
| MESH:D001930 | Brain Injuries |  | Progesterone | 4.33 | 15665606	15380490	15845082 | 
| MESH:D001943 | Breast Neoplasms |  | bisphenol A | 2.05 | 17123778 | 
| MESH:D001943 | Breast Neoplasms |  | decitabine | 2.05 | 18320071	19208741 | 
| MESH:D001943 | Breast Neoplasms |  | Methotrexate | 2.05 | 16978400 | 
| MESH:D001943 | Breast Neoplasms |  | Progesterone | 2.05 | 17614352	15562024	16175315 | 
| MESH:D002051 | Burkitt Lymphoma |  | arsenic trioxide | 4.39 | 11589617 | 
| MESH:D002252 | Carbon Tetrachloride Poisoning |  | Vitamin E | 4.00 | 16050911 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,4-dinitrotoluene | 4.63 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | 2,6-dinitrotoluene | 4.63 | 16705839 | 
| MESH:D006528 | Carcinoma, Hepatocellular |  | arsenic trioxide | 4.63 | 14691202	15073043	16217749	11135700	15553829 | 
| MESH:D002278 | Carcinoma in Situ |  | bisphenol A | 5.07 | 17123778 | 
| MESH:D002291 | Carcinoma, Papillary |  | arsenic trioxide | 4.97 | 19014326 | 
| MESH:D018288 | Carcinoma, Small Cell |  | arsenic trioxide | 4.17 | 12490120 | 
| MESH:D002294 | Carcinoma, Squamous Cell |  | decitabine | 2.61 | 19215824 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 2,6-dinitrotoluene | 11.35 | 6135515 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 11.35 | 20889678 | 
| MESH:D002471 | Cell Transformation, Neoplastic |  | Cyclosporine | 11.35 | 12371664 | 
| MESH:D002779 | Cholestasis |  | Cyclosporine | 2.95 | 19486331 | 
| MESH:D003092 | Colitis |  | Selenium | 3.85 | 17936198 | 
| MESH:D003110 | Colonic Neoplasms |  | decitabine | 2.34 | 17616700 | 
| MESH:D015179 | Colorectal Neoplasms |  | arsenic trioxide | 2.59 | 20501625 | 
| MESH:D015179 | Colorectal Neoplasms |  | decitabine | 2.59 | 18981723 | 
| MESH:D023903 | Coronary Restenosis |  | arsenic trioxide | 4.25 | 12609071 | 
| MESH:D019465 | Craniofacial Abnormalities |  | arsenic trioxide | 3.99 | 10525206 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Methotrexate | 3.99 | 12039119	9562676 | 
| MESH:D019465 | Craniofacial Abnormalities |  | Vitamin E | 3.99 | 19769572 | 
| MESH:D003490 | Cyanosis |  | 2,4-dinitrotoluene | 11.14 | 18551238 | 
| MESH:D003490 | Cyanosis |  | 2,6-dinitrotoluene | 11.14 | 18551238 | 
| MESH:D003550 | Cystic Fibrosis |  | Methotrexate | 4.29 | 19747007 | 
| MESH:D016757 | Death, Sudden, Cardiac |  | arsenic trioxide | 4.15 | 15213294 | 
| MESH:D003882 | Dermatomyositis |  | Methotrexate | 5.19 | 20191521 | 
| MESH:D003929 | Diabetic Neuropathies |  | Progesterone | 4.56 | 17187935 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,4-dinitrotoluene | 6.34 | 21346803	18551238 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | 2,6-dinitrotoluene | 6.34 | 21346803	18551238 | 
| MESH:D056486 | Drug-Induced Liver Injury |  | Selenium | 6.34 | 15131321 | 
| MESH:C538011 | Eales disease |  | Vitamin E | 4.80 | 9068938 | 
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental |  | Progesterone | 3.84 | 17692515 | 
| MESH:D004701 | Endocrine Gland Neoplasms |  | decitabine | 5.21 | 19294695 | 
| MESH:D004715 | Endometriosis |  | Progesterone | 3.82 | 16134523 | 
| MESH:D004938 | Esophageal Neoplasms |  | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 4.50 | 20426865 | 
| MESH:D004938 | Esophageal Neoplasms |  | arsenic trioxide | 4.50 | 12903497 | 
| MESH:D005234 | Fatty Liver |  | arsenic trioxide | 7.93 | 15073043 | 
| MESH:D005234 | Fatty Liver |  | Cyclosporine | 7.93 | 19224547 | 
| MESH:D005355 | Fibrosis |  | Cyclosporine | 3.21 | 12168785	12639820 | 
| MESH:D005706 | Gallbladder Neoplasms |  | arsenic trioxide | 4.33 | 16904648 | 
| MESH:D005885 | Gingival Hyperplasia |  | Cyclosporine | 4.30 | 8708960 | 
| MESH:D006086 | Graft vs Host Disease |  | Methotrexate | 5.22 | 16518429 | 
| MESH:D006258 | Head and Neck Neoplasms |  | decitabine | 3.52 | 19215824 | 
| MESH:D006330 | Heart Defects, Congenital |  | Vitamin E | 3.01 | 16080930 | 
| MESH:D006333 | Heart Failure |  | Selenium | 3.11 | 17162251 | 
| MESH:D006457 | Hemoglobinuria, Paroxysmal |  | Cyclosporine | 4.50 | 15720958 | 
| MESH:D006548 | Hernia, Diaphragmatic |  | Vitamin E | 2.72 | 16490937	16863852 | 
| MESH:D019247 | HIV Wasting Syndrome |  | testosterone enanthate | 5.84 | 17440010 | 
| MESH:D019584 | Hot Flashes |  | Vitamin E | 4.07 | 14716179 | 
| MESH:D006973 | Hypertension |  | Cyclosporine | 2.12 | 10903974 | 
| MESH:D020244 | Infarction, Middle Cerebral Artery |  | Progesterone | 4.47 | 15869954 | 
| MESH:D007248 | Infertility, Male |  | decitabine | 3.24 | 17581917 | 
| MESH:D007249 | Inflammation |  | Progesterone | 2.62 | 15869954 | 
| MESH:D007251 | Influenza, Human |  | Selenium | 11.29 | 16624496 | 
| MESH:D007251 | Influenza, Human |  | Vitamin E | 11.29 | 16624496 | 
| MESH:D007333 | Insulin Resistance |  | bisphenol A | 3.32 | 16393666 | 
| MESH:D007638 | Keratoconjunctivitis Sicca |  | Cyclosporine | 4.54 | 15604871 | 
| MESH:D007674 | Kidney Diseases |  | Cyclosporine | 6.12 | 8314463	10903974	18776723 | 
| MESH:D007674 | Kidney Diseases |  | Vitamin E | 6.12 | 12488133 | 
| MESH:D007676 | Kidney Failure, Chronic |  | Selenium | 3.94 | 16518626 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,4-dinitrotoluene | 12.63 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | 2,6-dinitrotoluene | 12.63 | 16705839 | 
| MESH:D007680 | Kidney Neoplasms |  | Cyclosporine | 12.63 | 12371664 | 
| MESH:D007805 | Language Development Disorders |  | Methotrexate | 5.16 | 9562676 | 
| MESH:D007938 | Leukemia |  | arsenic trioxide | 6.54 | 15070760 | 
| MESH:D007938 | Leukemia |  | decitabine | 6.54 | 18980019	19235587 | 
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell |  | arsenic trioxide | 3.85 | 17077332	12560223 | 
| MESH:D007948 | Leukemia, Monocytic, Acute |  | arsenic trioxide | 4.39 | 16972261 | 
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |  | arsenic trioxide | 3.47 | 14633726 | 
| MESH:D007951 | Leukemia, Myeloid |  | arsenic trioxide | 9.77 | 19077051 | 
| MESH:D007951 | Leukemia, Myeloid |  | decitabine | 9.77 | 18454857	19117987	17236224 | 
| MESH:D015470 | Leukemia, Myeloid, Acute |  | arsenic trioxide | 4.02 | 20471514	19850784	17050201	16467208	16968895 | 
| MESH:D015470 | Leukemia, Myeloid, Acute |  | decitabine | 4.02 | 19010910	17679729	18206229	18460780	19387464	18704418 | 
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic |  | decitabine | 5.56 | 18055864 | 
| MESH:D015473 | Leukemia, Promyelocytic, Acute |  | arsenic trioxide | 3.25 | 15622746	15748426	19075265	15336539	17217047	11161223	9834237	16966277	19035177	12679006	19642359	16330433	16891316	19225113	16823087	17869043	17712046	16331271	15213294	11468182	17649720	16112521	17107899	12018890	12712474 | 
| MESH:D015458 | Leukemia, T-Cell |  | arsenic trioxide | 4.42 | 16882451 | 
| MESH:D008103 | Liver Cirrhosis |  | Methotrexate | 3.73 | 14986274 | 
| MESH:D008106 | Liver Cirrhosis, Experimental |  | Vitamin E | 1.90 | 16169303 | 
| MESH:D008113 | Liver Neoplasms |  | 2,6-dinitrotoluene | 7.72 | 7678174 | 
| MESH:D008113 | Liver Neoplasms |  | arsenic trioxide | 7.72 | 14682389 | 
| MESH:D008113 | Liver Neoplasms |  | Mitomycin | 7.72 | 15113037 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | 2,6-dinitrotoluene | 6.07 | 2876786	6135515	2876784 | 
| MESH:D008114 | Liver Neoplasms, Experimental |  | arsenic trioxide | 6.07 | 20377131 | 
| MESH:D008133 | Long QT Syndrome |  | arsenic trioxide | 3.39 | 15213294 | 
| MESH:D008171 | Lung Diseases |  | Vitamin E | 3.21 | 16863852 | 
| MESH:D017563 | Lung Diseases, Interstitial |  | Methotrexate | 5.12 | 18516814 | 
| MESH:D008175 | Lung Neoplasms |  | arsenic trioxide | 2.55 | 19825857	11798837 | 
| MESH:D008175 | Lung Neoplasms |  | Vitamin E | 2.55 | 11062179 | 
| MESH:D008223 | Lymphoma |  | decitabine | 8.03 | 19470736 | 
| MESH:D008223 | Lymphoma |  | Methotrexate | 8.03 | 17352296 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Progesterone | 6.24 | 11408345	17203775 | 
| MESH:D008325 | Mammary Neoplasms, Experimental |  | Selenium | 6.24 | 15318939 | 
| MESH:D008545 | Melanoma |  | decitabine | 2.25 | 17785578	16505122 | 
| MESH:D008654 | Mesothelioma |  | Selenium | 2.81 | 15107826 | 
| MESH:D008664 | Metal Metabolism, Inborn Errors |  | Cyclosporine | 4.88 | 16801185 | 
| MESH:C536987 | Mosaic variegated aneuploidy syndrome | marker/mechanism |  |  | 21552266 | 
| MESH:D052016 | Mucositis |  | Methotrexate | 5.36 | 17488658 | 
| MESH:D009101 | Multiple Myeloma |  | arsenic trioxide | 7.50 | 14977855	19417148	15949261	19549372	11468182 | 
| MESH:D009101 | Multiple Myeloma |  | decitabine | 7.50 | 18172295 | 
| MESH:D009182 | Mycosis Fungoides |  | arsenic trioxide | 4.77 | 18349030 | 
| MESH:D009190 | Myelodysplastic Syndromes |  | arsenic trioxide | 7.60 | 16105982	16882451 | 
| MESH:D009190 | Myelodysplastic Syndromes |  | decitabine | 7.60 | 19157545	16882708	19010910	18608210 | 
| MESH:D009336 | Necrosis |  | 2,4-dinitrotoluene | 10.63 | 18551238 | 
| MESH:D009336 | Necrosis |  | 2,6-dinitrotoluene | 10.63 | 18551238	7678174 | 
| MESH:D009361 | Neoplasm Invasiveness |  | arsenic trioxide | 4.02 | 16624393 | 
| MESH:D009369 | Neoplasms |  | decitabine | 2.73 | 19116145	17925555	19470736 | 
| MESH:D009402 | Nephrosis, Lipoid |  | Cyclosporine | 4.54 | 17954296 | 
| MESH:D009404 | Nephrotic Syndrome |  | Cyclosporine | 3.33 | 19348381	18481113 | 
| MESH:D009421 | Nervous System Malformations |  | bisphenol A | 4.04 | 11399458	16427766 | 
| MESH:D009436 | Neural Tube Defects |  | arsenic trioxide | 3.15 | 10525206 | 
| MESH:D009784 | Occupational Diseases |  | 2,4-dinitrotoluene | 9.06 | 12819281	16049721 | 
| MESH:D009784 | Occupational Diseases |  | 2,6-dinitrotoluene | 9.06 | 16049721 | 
| MESH:D010049 | Ovarian Diseases |  | bisphenol A | 5.07 | 11985600 | 
| MESH:D010051 | Ovarian Neoplasms |  | arsenic trioxide | 8.05 | 19769630	16624393	12452020 | 
| MESH:D010051 | Ovarian Neoplasms |  | decitabine | 8.05 | 19331143	19259094 | 
| MESH:D010051 | Ovarian Neoplasms |  | Progesterone | 8.05 | 17393432	16525653 | 
| MESH:D010190 | Pancreatic Neoplasms |  | arsenic trioxide | 8.90 | 15580305 | 
| MESH:D010190 | Pancreatic Neoplasms |  | decitabine | 8.90 | 19294695 | 
| MESH:D010190 | Pancreatic Neoplasms |  | Mitomycin | 8.90 | 15113037 | 
| MESH:D010235 | Paraganglioma |  | arsenic trioxide | 4.22 | 19927285 | 
| MESH:D010954 | Plasmacytoma |  | Selenium | 4.99 | 15087411 | 
| MESH:D011230 | Precancerous Conditions |  | Cyclosporine | 3.27 | 12371664 | 
| MESH:D011297 | Prenatal Exposure Delayed Effects |  | bisphenol A | 4.03 | 10548101 | 
| MESH:D055728 | Primary Myelofibrosis |  | decitabine | 4.80 | 17616702 | 
| MESH:D019048 | Prostatic Intraepithelial Neoplasia |  | bisphenol A | 4.26 | 20887781 | 
| MESH:D011471 | Prostatic Neoplasms |  | arsenic trioxide | 2.60 | 19131511 | 
| MESH:D011471 | Prostatic Neoplasms |  | bisphenol A | 2.60 | 16740699 | 
| MESH:D011471 | Prostatic Neoplasms |  | Vitamin E | 2.60 | 15084515 | 
| MESH:D011565 | Psoriasis |  | Cyclosporine | 5.97 | 16882103 | 
| MESH:D011565 | Psoriasis |  | Methotrexate | 5.97 | 17410198 | 
| MESH:D011629 | Puberty, Precocious |  | bisphenol A | 4.87 | 10548101 | 
| MESH:D051437 | Renal Insufficiency |  | Methotrexate | 4.78 | 17352296 | 
| MESH:D012208 | Rhabdomyosarcoma |  | decitabine | 4.46 | 19155313 | 
| MESH:D012468 | Salivary Gland Neoplasms |  | Progesterone | 2.87 | 18045962 | 
| MESH:D012512 | Sarcoma, Ewing's |  | arsenic trioxide | 4.02 | 16646077 | 
| MESH:D012640 | Seizures |  | 2,4-dinitrotoluene | 5.99 | 18551238 | 
| MESH:D012640 | Seizures |  | 2,6-dinitrotoluene | 5.99 | 18551238 | 
| MESH:D012871 | Skin Diseases |  | Vitamin E | 2.45 | 18709164 | 
| MESH:D012878 | Skin Neoplasms |  | tert-Butylhydroperoxide | 2.71 | 8532709 | 
| MESH:D013119 | Spinal Cord Injuries |  | Progesterone | 4.36 | 16503802	15862959 | 
| MESH:D013274 | Stomach Neoplasms |  | arsenic trioxide | 2.58 | 17007042 | 
| MESH:D013274 | Stomach Neoplasms |  | decitabine | 2.58 | 19037991 | 
| MESH:D020521 | Stroke |  | Vitamin E | 3.56 | 16517955 | 
| MESH:D019966 | Substance-Related Disorders |  | bisphenol A | 4.07 | 16684133	16045194 | 
| MESH:D013576 | Syndactyly |  | Methotrexate | 5.10 | 9562676 | 
| MESH:D013964 | Thyroid Neoplasms |  | arsenic trioxide | 7.46 | 19014326 | 
| MESH:D013964 | Thyroid Neoplasms |  | decitabine | 7.46 | 17967635 | 
| MESH:D016171 | Torsades de Pointes |  | arsenic trioxide | 4.04 | 15213294 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,4-dinitrotoluene | 12.11 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | 2,6-dinitrotoluene | 12.11 | 16049721 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | arsenic trioxide | 12.11 | 12845720	20435036	11780464	12973940 | 
| MESH:D001749 | Urinary Bladder Neoplasms |  | decitabine | 12.11 | 17616700	19087683 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,4-dinitrotoluene | 12.27 | 10091137 | 
| MESH:D014571 | Urologic Neoplasms |  | 2,6-dinitrotoluene | 12.27 | 10091137 | 
| MESH:D014591 | Uterine Diseases |  | bisphenol A | 5.11 | 14652134 | 
| MESH:D014604 | Uveal Neoplasms |  | decitabine | 5.01 | 17785578 | 
| MESH:D014605 | Uveitis |  | Cyclosporine | 4.08 | 1336536 | 
| MESH:D014985 | Xerophthalmia |  | Cyclosporine | 4.54 | 17120751 |